NAVIGATION

April 29, 2016
Prevacus

Photo:

Jacob VanLandingham

Profile

Prevacus

| 2/22/2013

Neuroscientist Jacob VanLandingham, an assistant professor at Florida State University's college of medicine, began research in 2004 to develop a drug to treat concussions. "We recognized within the last few years between military and sports injuries, that concussions have become an epidemic, so we made an effort to find something for this population." The result: VanLandingham recently patented a neurosteroid drug and launched a company, Prevacus, at Tallahassee’s Innovation Park, for work on funding, preclinical trials and product refinement. The development has sparked interest from the Department of Defense and from the University of Pittsburgh Medical Center, a professional sports affiliate that has agreed to help with clinical trials, which could begin within the next 18 to 36 months.

Tags: Trendsetters, Healthcare, Research & Development

Digital Access

DIRECT DIGITAL ACCESS
Add digital to your current subscription, purchase a single digital issue, or start a new subscription to Florida Trend.

TABLE OF CONTENTS
An overview of the features and articles in this month's issue of Florida Trend.

ACCESS THIS ISSUE »

Florida Business News

Florida Trend Video Pick

Curbing food misrepresentation
Curbing food misrepresentation

Florida's Agriculture Commissioner Wednesday said the state needs to better understand the definition of "Fresh from Florida," and more thoroughly police the claims restaurateurs make to customers.

Earlier Videos | Viewpoints@FloridaTrend

Ballot Box

Do you think Gov. Scott and members of his cabinet will come to an agreement on the state insurance commissioner appointment on Friday?

  • Yes
  • Maybe by Monday, May 2
  • No, and -- we should accept outgoing Insurance Commissioner Kevin McCarty's offer to stay on until they can find a replacement

See Results

Ballot Box
Subscribe